Home › NDC Lookup › RxCUI directory › RxCUI 892648

Morphine sulfate 200 MG Extended Release Oral Tablet [MS Contin] — RxCUI 892648

RxNorm drug concept · Semantic branded drug
RxCUI 892648 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI892648
Official nameMorphine sulfate 200 MG Extended Release Oral Tablet [MS Contin]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asMS Contin 200 MG Extended Release Oral Tablet; MS 200 MG Extended Release Oral Tablet [MS Contin]
FDA products mapped3
Package NDCs mapped3
Reported Medicaid activity (SDUD)50 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Morphine Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Morphine injection is used to relieve severe pain — the kind that hasn't responded well enough to other treatments. It's not used for mild or moderate pain. Depending on the produc...
  • What is morphine injection actually used for?
  • When morphine is given near your spinal cord — either in the epidural space or directly into the spinal fluid — it can cause your breathing to slow down dangerously, even hours aft...
  • Why do I have to be watched so closely after getting the epidural or spinal version?
📖 Read our full Morphine Injection guide →

🕸️ Concept Web — How Morphine sulfate 200 MG Extended Release Oral Ta... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Morphine sulfate 200 MG Extended Release Oral Tablet [MS Contin] RxCUI 892648

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Morphine 7052
    • Morphine sulfate 30236
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • MS Contin 203354
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Morphine Extended Release Oral Tablet 372960
    • Morphine sulfate Extended Release Oral Tablet 2645326
    • Morphine Oral Product 1156363
    • Morphine Pill 1156364
    • Morphine sulfate Oral Product 2661613
    • Morphine sulfate Pill 2661827
    • Morphine Extended Release Oral Tablet [MS Contin] 369896
    • Morphine sulfate Extended Release Oral Tablet [MS Contin] 2656258
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Morphine sulfate 200 MG Extended Release Oral Tablet SCD · 892646
  • Morphine sulfate 200 MG SCDC · 892642
  • Morphine Extended Release Oral Tablet SCDF · 372960
  • Morphine sulfate Extended Release Oral Tablet SCDFP · 2645326
  • Morphine Oral Product SCDG · 1156363
  • Morphine Pill SCDG · 1156364
  • Morphine sulfate Oral Product SCDGP · 2661613
  • Morphine sulfate Pill SCDGP · 2661827

Brand-Name Concepts

  • Morphine sulfate 200 MG [MS Contin] SBDC · 892647
  • Morphine Extended Release Oral Tablet [MS Contin] SBDF · 369896
  • Morphine sulfate Extended Release Oral Tablet [MS Contin] SBDFP · 2656258
  • MS Contin Oral Product SBDG · 1184943
  • MS Contin Pill SBDG · 1184944
  • MS Contin BN · 203354

📦 FDA Products & Package NDCs

3 products · 3 package NDCs
3 package NDCs map to RxCUI 892648 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
42858-0515-01 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLAST... MS Contin Rhodes Pharmaceuticals LLC 2017-05-15
42858-0631-01 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLAST... MS Contin Rhodes Pharmaceuticals LLC 2017-05-15
42858-0760-01 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLAST... MS Contin Rhodes Pharmaceuticals LLC 2017-05-15
Observed labelers: Rhodes Pharmaceuticals LLC (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.